UPMC- RxAnte, a leading provider of solutions that improve the use of prescription medications, announced today that it has received a growth equity investment from UPMC Enterprises. Under the terms of the transaction closed on Sept. 30, Millennium Health sold its entire interest in RxAnte, which will continue to operate as an independent company, led by its existing management team.
Recent Posts
One year and five companies later, the Translational Sciences team is making a big impact at UPMC Enterprises
Less than 18 months later, that Enterprises team is nearly 20 strong and already seeing …
Read More →
Life Sciences Week Recap: The future of health care is here in Pittsburgh
Pittsburgh Life Sciences Week took place May 13 – May 17 and featured local and …
Read More →